The Influence of Different Metal-Chelators on the Biological Profil of Nanoparticles for Gallium-68 Based Molecular Imaging

The use of metal chelators is becoming increasingly important in the development of new tracers for molecular imaging. With the rise of the field of nanotechnology, the fusion of both technologies has shown great potential for clinical applications. The pharmacokinetcs of nanoparticles can be monitored via positron emission tomography (PET) after surface modification and radiolabeling with positron emitting radionuclides. Different metal ion chelators can be used to facilitate labeling of the radionuclides and as a prerequisite, optimized radiolabeling procedure is necessary to prevent nanoparticle aggregation and degradation. However, the effects of chelator modification on nanoparticle pharmacokinetic properties have not been well studied and currently no studies to date have compared the biological effects of the use of different chelators in the surface modification of nanoparticles.

Milka Ternina, Brustbild, Profil

Signatur des Originals: S 36/G04633

Ignaz Pleyel, Brustbild, Profil

Signatur des Originals: S 36/G04971

Johann Sebastian Bach, Relief, Profil

Signatur des Originals: S 36/F00069

Ludwig van Beethoven, Relief, Profil

Signatur des Originals: S 36/F00117

Emma Brandes, Brustbild, Profil

Signatur des Originals: S 36/F00197

Hans von Bülow, Relief, Profil

Signatur des Originals: S 36/F00221

Georg Gordon Byron Byron, Relief, Profil

Signatur des Originals: S 36/F00250

Sophia Charlotte Cruvelli, Brustbild, Profil

Signatur des Originals: S 36/F00303

Sophia Charlotte Cruvelli, Brustbild, Profil

Signatur des Originals: S 36/F00304

Christoph Willibald Gluck, Relief, Profil

Signatur des Originals: S 36/F00555